Kimmel April D, Pan Zhongzhe, Murenzi Gad, Brazier Ellen, Elul Batya, Muhoza Benjamin, Yotebieng Marcel, Anastos Kathryn, Nash Denis
Department of Health Policy, Virginia Commonwealth University School of Public Health, Richmond, USA.
Division of Infectious Diseases, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, USA.
medRxiv. 2025 Apr 26:2025.04.25.25326450. doi: 10.1101/2025.04.25.25326450.
HIV prevention and treatment supported by the United States President's Emergency Plan for AIDS Relief (PEPFAR) have saved millions of lives. Rwanda is among the most successful countries around the world in achieving global targets with PEPFAR support. However, abrupt funding uncertainty around PEPFAR raises concerns about continued HIV epidemic control. We projected the impact of the Government of Rwanda's (GoR's) capacity to offset the elimination of PEPFAR funding on adult HIV epidemic and care continuum outcomes over 10 years.
Using an HIV policy model calibrated to Rwanda, we assessed: capacity to sustain HIV services at 50% (with no capacity by GoR to cover the PEPFAR funding gap), 75%, 90%, and 100% (with full capacity by GoR to cover the PEPFAR funding gap). Scenarios were operationalized by reducing the number on antiretroviral therapy (ART), with immediate ART discontinuation and proportional decreases in HIV diagnosis, ART initiation, and care re-engagement. We projected HIV epidemic outcomes (HIV prevalence, HIV incidence, number with HIV, new HIV infections, deaths) and care continuum outcomes (percent diagnosed, percent on ART among those diagnosed, percent virally suppressed among those on ART). We calculated differences in projected outcomes for partial or no capacity versus full capacity. Secondary analyses assessed delayed coverage capacity by 1 and 3 years.
Compared to full capacity at 10 years, the model projected a 13.9%-38.7% increase in HIV prevalence and 69.0%-246.7% increase in HIV incidence across coverage capacity scenarios. This translated to 29,000-64,000 additional adults with HIV and 20,000-92,000 cumulative new adult HIV infections. Cumulative projected deaths increased by 10,000-51,200. The model projected continual reductions in percent diagnosed at 10 years; percent virally suppressed among those on ART was similar across scenarios. Higher, and more delayed, coverage capacity had projected outcomes similar to lower, and less delayed, coverage capacity.
Even in countries like Rwanda that have achieved epidemic control, abrupt and persistent elimination of PEPFAR funding could drastically reverse critical gains. Evidence quantifying the consequences of different capacities to sustain HIV services underscores the high stakes of rapid and sufficient action.
由美国总统艾滋病紧急救援计划(PEPFAR)支持的艾滋病预防和治疗挽救了数百万人的生命。卢旺达是在PEPFAR支持下实现全球目标最成功的国家之一。然而,PEPFAR资金的突然不确定性引发了对艾滋病持续防控的担忧。我们预测了卢旺达政府抵消PEPFAR资金消除对成人艾滋病疫情及10年护理连续结果的影响。
使用针对卢旺达校准的艾滋病政策模型,我们评估了:维持艾滋病服务能力达到50%(卢旺达政府无能力填补PEPFAR资金缺口)、75%、90%和100%(卢旺达政府有充分能力填补PEPFAR资金缺口)的情况。通过减少抗逆转录病毒疗法(ART)人数来实施不同情景,即立即停止ART,并按比例减少艾滋病诊断、ART启动和护理重新参与人数。我们预测了艾滋病疫情结果(艾滋病流行率、艾滋病发病率、艾滋病患者人数、新的艾滋病感染人数、死亡人数)和护理连续结果(诊断百分比、诊断者中接受ART的百分比、接受ART者中病毒得到抑制的百分比)。我们计算了部分或无能力与充分能力情况下预测结果的差异。二次分析评估了延迟1年和3年的覆盖能力。
与10年时的充分能力相比,该模型预测在不同覆盖能力情景下,艾滋病流行率将增加13.9%-38.7%,艾滋病发病率将增加69.0%-246.7%。这意味着新增29,000-64,000名成年艾滋病患者以及20,000-92,000例成年新增艾滋病感染病例。预计累计死亡人数增加10,000-51,200人。该模型预测10年时诊断百分比将持续下降;不同情景下接受ART者中病毒得到抑制的百分比相似。更高且更延迟的覆盖能力所预测的结果与更低且更不延迟的覆盖能力相似。
即使在像卢旺达这样已实现疫情控制的国家,突然且持续地消除PEPFAR资金可能会大幅逆转关键成果。量化维持艾滋病服务不同能力后果的证据凸显了迅速采取充分行动的重大风险。